The Central Board of Trustees has revised Employees' Provident Fund Organisation rules. New regulations have changed EPF ...

Abbott reaffirms previously provided full-year 2025 organic sales growth guidance of 7.5% to 8.0%, excluding COVID-19 testing-related sales, or 6.0% to 7.0%, when including COVID-19 testing-related ...

EPFO has released FAQs on the Revamped Electronic Challan-cum-Return (ECR) system, mandatory from the September 2025 wage month. The new process separates return submission from payment, incorporates ...

Investing.com - Abbott Labs (NYSE: ABT) reported third quarter EPS of $1.30, in line with the analyst estimate of $1.30. Revenue for the quarter came in at $11.37B versus the consensus estimate of $11 ...

From Bill Demchak, PNC Chairman and Chief Executive Officer: "We delivered another great quarter with better than expected financial results and steady client growth across all ou ...